Kelly Huller - Nov 6, 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Signature
/s/ Kelly G. Huller
Stock symbol
GMED
Transactions as of
Nov 6, 2024
Transactions value $
-$284,000
Form type
4
Date filed
11/8/2024, 04:21 PM
Previous filing
Oct 18, 2024
Next filing
Dec 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $121K +5K $24.21 5K Nov 6, 2024 Direct
transaction GMED Class A Common Stock Sale -$200K -2.5K -50% $80.02 2.5K Nov 6, 2024 Direct F1
transaction GMED Class A Common Stock Sale -$205K -2.5K -100% $82.00 0 Nov 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -5K -66.67% $0.00 2.5K Nov 6, 2024 Class A Common Stock 5K $24.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person.
F2 These options were granted on February 2, 2016 and are fully vested.